G. Mahla

Efficacy and safety of a new cholesterol synthesis inhibitor, atorvastatin, in comparison with simvastatin and pravastatin, in subjects with hypercholesterolemia.

B. Wolffenbuttel, D. Black, G. Mahla, 1998, The Netherlands journal of medicine.

Effects of acarbose treatment in Type 2 diabetic patients under dietary training: a multicentre, double-blind, placebo-controlled, 2-year study.

D. Heim, G. Mertes, G. Mahla, 1999, Diabetes, nutrition & metabolism.

Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia.

C. Sirtori, S. Bertolini, M. Farnier, 1997, Atherosclerosis.

Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy

J. Brachmann, S. Klebs, R. Handrock, 2008, Advances in therapy.

Rosuvastatin Demonstrates Greater Reduction of Low-Density Lipoprotein Cholesterol Compared with Pravastatin and Simvastatin in Hypercholesterolaemic Patients: A Randomized, Double-Blind Study

R. Paoletti, H. Southworth, G. Mahla, 2001, Journal of cardiovascular risk.

Double-Blind Comparison of Apolipoprotein and Lipoprotein Particle Lowering Effects of Atorvastatin and Pravastatin Monotherapy in Patients With Primary Hypercholesterolemia

C. Sirtori, J. Dallongeville, J. Fruchart, 1998, Journal of cardiovascular pharmacology and therapeutics.